Edge Wealth Management LLC Marker Therapeutics, Inc. Transaction History

Edge Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$1.5 - $2.2 $20,250 - $29,700	-13,500 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$1.69 - $2.79 $13,520 - $22,320	8,000 Added 145.45%	13,500 $28,000
Q1 2020 Apr 20, 2020	SELL	$1.59 - $3.35 $3,975 - $8,375	-2,500 Reduced 31.25%	5,500 $10,000
Q4 2019 Jan 29, 2020	SELL	$2.68 - $4.85 $37,520 - $67,900	-14,000 Reduced 63.64%	8,000 $23,000
Q3 2019 Oct 21, 2019	BUY	$4.1 - $9.0 $82,000 - $180,000	20,000 Added 1000.0%	22,000 $112,000
Q2 2019 Jul 15, 2019	BUY	$5.15 - $7.92 $10,300 - $15,840	2,000 New	2,000 $15,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $100M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.